2011

• Klein, C., Karanges, E., Spiro, A., Wong, A., Spencer, J., Huynh, T., Gunasekaran, N., Karl, T., Long, L., Huang, X., Liu, K., Arnold, J., McGregor, I. (2011), Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats. Psychopharmacology. 218(2), 443-57. [Abstract]
• Boucher, A., Arnold, J., Hunt, G., Spiro, A., Spencer, J., Brown, C., McGregor, I., Bennett, M., Kassiou, M. (2011), Resilience and reduced c-Fos expression in P2X7 receptor knockout mice exposed to repeated forced swim test. Neuroscience. 189(2011), 170-7. [Abstract]
• Sokolic, L., Long, L., Hunt, G., Arnold, J., McGregor, I. (2011), Disruptive effects of the prototypical cannabinoid Δ9-tetrahydrocannabinol and the fatty acid amide inhibitor URB-597 on go/no-go auditory discrimination performance and olfactory reversal learning in rats. Behavioural Pharmacology. 22(3), 191-202. [Abstract]
• Boucher, A., Hunt, G., Micheau, J., Huang, X., McGregor, I., Karl, T., Arnold, J. (2011), The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids. The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP). 14, 631-43. [Abstract]
• Bowen, M., Carson, D., Spiro, A., Arnold, J., McGregor, I. (2011), Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats. PloS One. 6(11), e27237. [Abstract]

2010

• van Nieuwenhuijzen, P., Long, L., Hunt, G., Arnold, J., McGregor, I. (2010), Residual social, memory and oxytocin-related changes in rats following repeated exposure to gamma-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination. Psychopharmacology. 212, 663-74. [Abstract]
• Arnold, J., Dielenberg, R., McGregor, I. (2010), Cannabinoids increase conditioned ultrasonic vocalisations and cat odour avoidance in rats: Strain differences in drug-induced anxiety. Life sciences. 87(17-18), 572-8. [Abstract]
• Carson, D., Hunt, G., Guastella, A., Barber, L., Cornish, J., Arnold, J., Boucher, A., McGregor, I. (2010), Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addiction biology. 15(4), 448-63. [Abstract]
• Long, L., Chesworth, R., Arnold, J., Karl, T. (2010), A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice. Psychopharmacology. 211(3), 277-289. [Abstract]

2009

• Gunasekaran, N., Long, L., Dawson, B., Hansen, G., Richardson, D., Li, K., Arnold, J., McGregor, I. (2009), Reintoxication: the release of fat-stored Delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure. British Journal of Pharmacology. 158(5), 1330-1337. [Abstract]
• Boucher, A., Vivier, L., Metna-Laurent, M., Brayda-Bruno, L., Mons, N., Arnold, J., Micheau, J. (2009), Chronic treatment with Delta(9)-tetrahydrocannabinol impairs spatial memory and reduces zif268 expression in the mouse forebrain. Behavioural Pharmacology. 20(1), 45-55. [Abstract]

2008

• Jiwane, A., Holland, A., Soundappan, S., Arnold, J. (2008), An unusual case of bilious vomiting in a neonate. Journal of Paediatrics and Child Health. 44(12), 747-749. [Abstract]
• Holland, M., Allen, J., Arnold, J. (2008), Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1). European journal of pharmacology. 591, 128-31. [Abstract]
• Quinn, H., Matsumoto, I., Callaghan, P., Long, L., Arnold, J., Gunasekaran, N., Thompson, M., Dawson, B., Mallet, P., Kashem, M., Matsuda-Matsumoto, H., Iwazaki, T., McGregor, I. (2008), Adolescent Rats Find Repeated Delta(9)-THC Less Aversive Than Adult Rats but Display Greater Residual Cognitive Deficits and Changes in Hippocampal Protein Expression Following Exposure. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 33(0), 1113-26. [Abstract]

2007

• Boucher, A., Hunt, G., Karl, T., Micheau, J., McGregor, I., Arnold, J. (2007), Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression. Neuroscience. 149(4), 861-70. [Abstract]
• McGregor, I., Arnold, J. (2007), Cannabis reward: biased towards the fairer sex?. British journal of pharmacology. 152(5), 562-4. [Abstract]
• Holland, M., Lau, D., Allen, J., Arnold, J. (2007), The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids. British journal of pharmacology. 152(5), 815-24. [Abstract]
• Boucher, A., Arnold, J., Duffy, L., Schofield, P., Micheau, J., Karl, T. (2007), Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol. Psychopharmacology. 192(3), 325-336. [Abstract]

2006

• Karl, T., Duffy, L., Boucher, A., Arnold, J., Schofield, P. (2006), Genetic animal models for neuregulin 1 - valuable tools for schizophrenia research?. Australian and New Zealand Journal of Psychiatry. 40, A115-A115. [Abstract]
• Holland, M., Panetta, J., Hoskins, J., Bebawy, M., Roufogalis, B., Allen, J., Arnold, J. (2006), The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells. Biochemical pharmacology. 71(8), 1146-54. [Abstract]